WHO WE ARE
INTRODUCTION
Endovision helps to improve the diagnostic accuracy of the upper GI endoscopists ( doctor ) and saves their time, hence enabling them to perform better and faster using the power of deep learning and computational modeling.
ABOUT
OUR PRODUCT
Endoscopy is a medical diagnostic procedure in which the doctor has to make a diagnosis in real-time by looking at the live video of the internal organs in the digestive tract. We provide real-time AI assistance to the doctors, to help them reduce the burden of this hard and tedious procedure. We do this by tracking the progress of the endoscopy in real-time, hence targeting the inspection quality and completeness.
FEATURES OF OUR PRODUCT
OUR PARTNERS
PROF. PHILIP CHIU
Director of Endoscopy PWH, HK
Scientific Clinical Advisor
PROF. KENSHI YAO
Director of Endoscopy, Fukuoka hospital, Japan
DR SHANNON CHAN
DR. HON CHI YIP
DR PREM PILLAY
Neurosurgeon, Cleveland Clinic
DR MICHAEL GRYSEELS
Managing Partner McKinsey & Company
ELIZA CHONG
Healthcare Consultant, IQVIA Ex. Marketing lead, Medtronics
ARYA SETIADHARMA
Prasetia group
INVESTORS
Medtech Innovator
Startup Accelerator
Pureland Venture
Singapore based MedTech investor
Hong kong science park
Government funding and incubation
Faculty of Medicine, CUHK
Collaborating research institution
Entrepreneur First
Startup Accelerator
FROM OUR FOUNDERS AND PARTNERS
It is deeply rewarding to see this technology evolve from my initial concept to clinical translation with the potential to significantly improve patient outcomes.
Incomplete inspection of gastric mucosa remains a main reason for interval gastric cancer affecting the chance of survival of our patients. As proof-of-concept, Cerebro may assure a more complete inspection by assuring the visualization of all the landmarks. Additional clinical studies are desirable.
Cerebro assists endoscopists in navigating all key landmark points in the upper GI tract, ensuring a comprehensive and thorough examination without blind spots. The system operates with exceptional accuracy when the endoscope is maneuvered slowly, allowing for clear visualization of the landmarks, which ultimately enhances the quality of endoscopy. I am excited to witness how AI-driven technologies like this continue to improve patient care through improved endoscopy quality.
Announcing a pivotal moment for Endovision and the future of gastroenterology! Our AI Software as a Medical Device (SaMD), Cerebro, has received CE certification, positioning it as one of the first Computer-Aided Quantification (CAQ) tools for EGD. We are also thrilled to partner with Cosmo Pharmaceuticals, through which our AI will be available with Medtronic’s GI Genius™ intelligent endoscopy system. This marks a crucial step in realizing the long-awaited potential of AI to transform daily clinical practice, and we are excited to be at the forefront of this evolution.
